Apellis Announces Negative CHMP Opinion for Pegcetacoplan
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal ...
Read moreWALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal ...
Read moreARLINGTON, Va., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tunnl, an issue and cause-based audience intelligence platform specialized in helping advertisers ...
Read moreFriedreich’s ataxia is a genetic, debilitating and life-shortening neuromuscular disease1Milestone highlights Biogen’s growing portfolio in rare diseases and focus on ...
Read moreEMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found ...
Read moreMidea has today launched its new campaign #H9meAzingMoments featuring Manchester City striker and treble winner, Erling Haaland MANCHESTER, England, Dec. ...
Read moreAUSTIN, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate ...
Read moreCHMP positive opinion in the European Economic Area for first biosimilar to Stelara, a biologic therapy within gastroenterology, dermatology and ...
Read moreBRADFORD, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) today announced that an ...
Read moreSAN JOSE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ: AVGO) announced today that the German Federal Patent ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.